| |
Latest 10 SEC filings (by transaction date) for ABIO within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Jan 31/24 | Jan 30/24 | Ma-Weaver Jacob | Direct Ownership | Stock option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 6,000 | |
Jan 31/24 | Jan 30/24 | Hove Anders D | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 6,000 | |
Jan 31/24 | Jan 30/24 | Mitchell Daniel J | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 6,000 | |
Jan 31/24 | Jan 30/24 | Flynn James P | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 6,000 | |
Jan 31/24 | Jan 30/24 | Conway Robert E | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 6,000 | |
Jan 31/24 | Jan 30/24 | Grais Linda | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 6,000 | |
Jan 31/24 | Jan 30/24 | Woosley Raymond L. | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 6,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for ABIO within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Jan 31/24 | Jan 30/24 | Ma-Weaver Jacob | Direct Ownership | Stock option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 6,000 | |
Jan 31/24 | Jan 30/24 | Hove Anders D | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 6,000 | |
Jan 31/24 | Jan 30/24 | Mitchell Daniel J | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 6,000 | |
Jan 31/24 | Jan 30/24 | Flynn James P | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 6,000 | |
Jan 31/24 | Jan 30/24 | Conway Robert E | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 6,000 | |
Jan 31/24 | Jan 30/24 | Grais Linda | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 6,000 | |
Jan 31/24 | Jan 30/24 | Woosley Raymond L. | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 6,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Cerevel Therapeutics Hold (OQ:CERE) |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |